Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. En 2234a
2. En-2234a
3. En2234a
4. Nalbuphine
5. Nalbuphine Serb
6. Nubain
1. Nubain
2. Nalbuphine Hcl
3. 23277-43-2
4. Nalbuphine Hydrochloride [usan]
5. En-2234a
6. Nalbufine Hydrochloride
7. Nsc-757829
8. Zu4275277r
9. (4r,4as,7s,7ar,12bs)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol;hydrochloride
10. Nalbuphine Hydrochloride (usan)
11. Chebi:7455
12. Nalbufina Clorhidrato [spanish]
13. En 2234a
14. Einecs 245-549-9
15. Nalbuphinehydrochloride
16. Unii-zu4275277r
17. Prestwick_344
18. Nubain (tn)
19. 17-(cyclobutylmethyl)-4,5alpha-epoxymorphinan-3,6alpha,14-triol Hydrochloride
20. (5alpha,6alpha)-17-(cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol Hydrochloride
21. Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, Hydrochloride, (5-alpha,6-alpha)-
22. Schembl41123
23. Mls002154202
24. Chembl1201132
25. Dtxsid20177844
26. Hms1568g18
27. Nalbuphine Hydrochloride [mi]
28. Ccg-220118
29. Nsc 757829
30. Pw-4142
31. Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, Hydrochloride, (5alpha,6alpha)-
32. Morphinan-3,6-alpha,14-triol, 17-(cyclobutylmethyl)-4,5-alpha-epoxy-, Hydrochloride
33. Nalbuphine Hydrochloride [mart.]
34. Nalbuphine Hydrochloride [vandf]
35. Nalbuphine Hydrochloride [who-dd]
36. Bn161328
37. Smr001233488
38. Nalbuphine Hydrochloride [orange Book]
39. D00843
40. E98629
41. Q27107499
42. (-)-17-(cyclobutylmethyl)- 4,5a-epoxymorphinan- 3,6a,14-triol Hydrochloride
43. 17-(cyclobutylmethyl)-4,5.alpha.-epoxymorphinan-3,6.alpha.,14-triol Hydrochloride
44. Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, Hydrochloride, (5.alpha.,6.alpha.)-
45. Nalbuphine Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
| Molecular Weight | 393.9 g/mol |
|---|---|
| Molecular Formula | C21H28ClNO4 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 393.1706861 g/mol |
| Monoisotopic Mass | 393.1706861 g/mol |
| Topological Polar Surface Area | 73.2 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 597 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Nalbuphine hydrochloride |
| Drug Label | AmpulFliptop VialProtect from light.Rx OnlyNalbuphine hydrochloride is a synthetic opioid agonist-antagonist analgesic of the phenanthrene series. It is chemically related to both the widely used opioid antagonist, naloxone, and the potent opioid ana... |
| Active Ingredient | Nalbuphine hydrochloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 20mg/ml; 10mg/ml |
| Market Status | Prescription |
| Company | Hospira |
| 2 of 2 | |
|---|---|
| Drug Name | Nalbuphine hydrochloride |
| Drug Label | AmpulFliptop VialProtect from light.Rx OnlyNalbuphine hydrochloride is a synthetic opioid agonist-antagonist analgesic of the phenanthrene series. It is chemically related to both the widely used opioid antagonist, naloxone, and the potent opioid ana... |
| Active Ingredient | Nalbuphine hydrochloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 20mg/ml; 10mg/ml |
| Market Status | Prescription |
| Company | Hospira |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Date of Issue : 2025-02-11
Valid Till : 2027-06-09
Written Confirmation Number : WC-0278
Address of the Firm :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
NDC Package Code : 50396-0201
Start Marketing Date : 2018-06-19
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Deccan Nutraceuticals: A global leader in the integrated development, manufacturing, and marketing of pharmaceutical products.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
Date of Issue : 2025-02-11
Valid Till : 2027-06-09
Written Confirmation Number : WC-0278
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11421
Submission : 1995-03-31
Status : Active
Type : II
NDC Package Code : 0406-3360
Start Marketing Date : 2010-06-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2883
Submission : 1977-03-18
Status : Inactive
Type : II
NDC Package Code : 0406-3310
Start Marketing Date : 2013-11-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
NDC Package Code : 50396-0201
Start Marketing Date : 2018-06-19
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
NDC Package Code : 52465-106
Start Marketing Date : 2018-06-19
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-1546
Start Marketing Date : 2010-11-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...

NDC Package Code : 0406-3360
Start Marketing Date : 2010-06-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 0406-3310
Start Marketing Date : 2013-11-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 51927-2140
Start Marketing Date : 2013-06-20
End Marketing Date : 2028-02-28
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Reply
29 Mar 2025
Reply
12 Sep 2024
Reply
26 Nov 2022
Reply
24 Mar 2021
Reply
23 Feb 2021
Reply
07 Apr 2020
Reply
23 Oct 2019
Reply
21 Jun 2019
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
70
PharmaCompass offers a list of Nalbuphine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nalbuphine Hydrochloride manufacturer or Nalbuphine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nalbuphine Hydrochloride manufacturer or Nalbuphine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Nalbuphine Hydrochloride API Price utilized in the formulation of products. Nalbuphine Hydrochloride API Price is not always fixed or binding as the Nalbuphine Hydrochloride Price is obtained through a variety of data sources. The Nalbuphine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NALBUFINE HYDROCHLORIDE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NALBUFINE HYDROCHLORIDE, including repackagers and relabelers. The FDA regulates NALBUFINE HYDROCHLORIDE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NALBUFINE HYDROCHLORIDE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NALBUFINE HYDROCHLORIDE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A NALBUFINE HYDROCHLORIDE supplier is an individual or a company that provides NALBUFINE HYDROCHLORIDE active pharmaceutical ingredient (API) or NALBUFINE HYDROCHLORIDE finished formulations upon request. The NALBUFINE HYDROCHLORIDE suppliers may include NALBUFINE HYDROCHLORIDE API manufacturers, exporters, distributors and traders.
click here to find a list of NALBUFINE HYDROCHLORIDE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A NALBUFINE HYDROCHLORIDE DMF (Drug Master File) is a document detailing the whole manufacturing process of NALBUFINE HYDROCHLORIDE active pharmaceutical ingredient (API) in detail. Different forms of NALBUFINE HYDROCHLORIDE DMFs exist exist since differing nations have different regulations, such as NALBUFINE HYDROCHLORIDE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A NALBUFINE HYDROCHLORIDE DMF submitted to regulatory agencies in the US is known as a USDMF. NALBUFINE HYDROCHLORIDE USDMF includes data on NALBUFINE HYDROCHLORIDE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The NALBUFINE HYDROCHLORIDE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of NALBUFINE HYDROCHLORIDE suppliers with USDMF on PharmaCompass.
A NALBUFINE HYDROCHLORIDE written confirmation (NALBUFINE HYDROCHLORIDE WC) is an official document issued by a regulatory agency to a NALBUFINE HYDROCHLORIDE manufacturer, verifying that the manufacturing facility of a NALBUFINE HYDROCHLORIDE active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting NALBUFINE HYDROCHLORIDE APIs or NALBUFINE HYDROCHLORIDE finished pharmaceutical products to another nation, regulatory agencies frequently require a NALBUFINE HYDROCHLORIDE WC (written confirmation) as part of the regulatory process.
click here to find a list of NALBUFINE HYDROCHLORIDE suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing NALBUFINE HYDROCHLORIDE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for NALBUFINE HYDROCHLORIDE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture NALBUFINE HYDROCHLORIDE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain NALBUFINE HYDROCHLORIDE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a NALBUFINE HYDROCHLORIDE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of NALBUFINE HYDROCHLORIDE suppliers with NDC on PharmaCompass.
NALBUFINE HYDROCHLORIDE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NALBUFINE HYDROCHLORIDE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NALBUFINE HYDROCHLORIDE GMP manufacturer or NALBUFINE HYDROCHLORIDE GMP API supplier for your needs.
A NALBUFINE HYDROCHLORIDE CoA (Certificate of Analysis) is a formal document that attests to NALBUFINE HYDROCHLORIDE's compliance with NALBUFINE HYDROCHLORIDE specifications and serves as a tool for batch-level quality control.
NALBUFINE HYDROCHLORIDE CoA mostly includes findings from lab analyses of a specific batch. For each NALBUFINE HYDROCHLORIDE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NALBUFINE HYDROCHLORIDE may be tested according to a variety of international standards, such as European Pharmacopoeia (NALBUFINE HYDROCHLORIDE EP), NALBUFINE HYDROCHLORIDE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NALBUFINE HYDROCHLORIDE USP).